CUV 0.66% $15.10 clinuvel pharmaceuticals limited

Less self indulgent, value destroying newsletters, share...

  1. 592 Posts.
    lightbulb Created with Sketch. 279
    Less self indulgent, value destroying newsletters, share buyback, keamy leaving, removal of Blijdorp from board. Looks like Clinuvel may be starting to listen to shareholders. There is still a long list to go but let’s start with the board restructuring then a new CEO. Second strike may provide some motivation.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.